Then, we will have the ectopic xenograft ovarian cancer cell grow a tumor for 30 days before we evaluate the impact of chronic administration of CB2 (JWH-133) agonist for 30 days and starting injection of JWH-133 after 30 days of tumor growth. This evidence concerns the gene CNR2 and neoplasm.